Your browser doesn't support javascript.
loading
Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice.
Graham, Jessica B; Swarts, Jessica L; Leist, Sarah R; Schäfer, Alexandra; Menachery, Vineet D; Gralinski, Lisa E; Jeng, Sophia; Miller, Darla R; Mooney, Michael A; McWeeney, Shannon K; Ferris, Martin T; Pardo-Manuel de Villena, Fernando; Heise, Mark T; Baric, Ralph S; Lund, Jennifer M.
Afiliación
  • Graham JB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, Unites States of America.
  • Swarts JL; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, Unites States of America.
  • Leist SR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, Unites States of America.
  • Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, Unites States of America.
  • Menachery VD; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, Unites States of America.
  • Gralinski LE; Department of Microbiology and Immunology, University of Texas Medical Center, Galveston, Texas, Unites States of America.
  • Jeng S; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, Unites States of America.
  • Miller DR; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, Unites States of America.
  • Mooney MA; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, Oregon, Unites States of America.
  • McWeeney SK; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, Unites States of America.
  • Ferris MT; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, Unites States of America.
  • Pardo-Manuel de Villena F; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, Oregon, Unites States of America.
  • Heise MT; Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, Unites States of America.
  • Baric RS; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, Unites States of America.
  • Lund JM; Oregon Clinical and Translational Research Institute, Oregon Health & Science University, Portland, Oregon, Unites States of America.
PLoS Pathog ; 17(1): e1009287, 2021 01.
Article en En | MEDLINE | ID: mdl-33513210
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: PLoS Pathog Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: PLoS Pathog Año: 2021 Tipo del documento: Article